| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2005 | CN1665811A Carbamate-substituted pyrazolopyridines |
| 09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665808A Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase |
| 09/07/2005 | CN1665807A Novel physiolgically active substances |
| 09/07/2005 | CN1665806A Medicine compound |
| 09/07/2005 | CN1665805A Method for preparing optical purity or optically concentrated sulfoxide compounds comprising amorphous esomeprazole and its salts |
| 09/07/2005 | CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism |
| 09/07/2005 | CN1665803A Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| 09/07/2005 | CN1665801A Anti tubercular drug: compositions and methods |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665799A Motilide compounds |
| 09/07/2005 | CN1665798A Refreshment capable of stimulating movement of digestive tract |
| 09/07/2005 | CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 09/07/2005 | CN1665791A Quinazoline derivatives |
| 09/07/2005 | CN1665788A Pyrimidinone compounds, compositions and methods |
| 09/07/2005 | CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 09/07/2005 | CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives |
| 09/07/2005 | CN1665774A Cinnamide derivatives |
| 09/07/2005 | CN1665764A An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| 09/07/2005 | CN1665763A Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 09/07/2005 | CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c |
| 09/07/2005 | CN1665565A GHRELIN-carrier conjugates |
| 09/07/2005 | CN1665554A Compounds and method for coating surfaces in a haemocompatible manner |
| 09/07/2005 | CN1665545A Compound ablation mixture and its use in preparation of drugs for treating tumors |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665539A Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors |
| 09/07/2005 | CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665536A Use of CETP inhibitors and antihypertensive agents as well as optionally HMG COA reductase inhibitors |
| 09/07/2005 | CN1665535A Perylenequinones for use with immunotherapy agents |
| 09/07/2005 | CN1665525A Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665517A Ciclesonide-containing sterile aqueous suspension |
| 09/07/2005 | CN1665516A Infertility treatment with exemestane |
| 09/07/2005 | CN1665515A Methods for treating psychosis associated with interferon-alpha therapy |
| 09/07/2005 | CN1665514A Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells |
| 09/07/2005 | CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 09/07/2005 | CN1665511A Method of promoting smoking cessation |
| 09/07/2005 | CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders |
| 09/07/2005 | CN1665509A Synergistic interaction of abacavir and alovudine |
| 09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
| 09/07/2005 | CN1665507A Therapeutic 1, 2, 3, 6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 09/07/2005 | CN1665505A 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 09/07/2005 | CN1665504A Novel crystalline forms of gatifloxacin |
| 09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
| 09/07/2005 | CN1665502A MCHIR antagonists |
| 09/07/2005 | CN1665501A Novel compounds as opioid receptor modulators |
| 09/07/2005 | CN1665500A Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 09/07/2005 | CN1665499A Drug composition for prevention or inhibition of advance of diabetic complication |
| 09/07/2005 | CN1665498A Drug composition for blood sugar control |
| 09/07/2005 | CN1665497A Use of rotigotine for treating the restless leg syndrome |
| 09/07/2005 | CN1665496A Use of epa and dha in secondary prevention |
| 09/07/2005 | CN1665495A A process for preparing long chain saturated or unsaturated oxygenated compounds |
| 09/07/2005 | CN1665494A Polymer affinity matrix, a method for the production and use thereof |
| 09/07/2005 | CN1665493A Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 09/07/2005 | CN1665491A Microcapsules for the delayed, controlled release of perindopril |
| 09/07/2005 | CN1665490A 控释组合物 A controlled release composition |
| 09/07/2005 | CN1665488A Direct cellular energy delivery system |
| 09/07/2005 | CN1665486A Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 09/07/2005 | CN1665485A Compositions and methods for amelioration of human female sexual dysfunction |
| 09/07/2005 | CN1665484A Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/07/2005 | CN1665483A Solid dispersion comprising two different polymer matrixes |
| 09/07/2005 | CN1665482A Methods and dosage forms for controlled delivery of oxycodone |
| 09/07/2005 | CN1665403A Beverages containing plant sterols |
| 09/07/2005 | CN1665401A Vitamin-containing system for stabilising the immune response of animals |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/07/2005 | CN1663957A Micromolecule interference RNA aiming at middle period factor gene and use thereof |
| 09/07/2005 | CN1663616A Rotavirus gene vaccine based on NSP4 gene |
| 09/07/2005 | CN1663614A 复方氨溴索和头孢菌素类制剂及其应用 Compound ambroxol and cephalosporins preparation and its application |
| 09/07/2005 | CN1663571A Polysaccharide biological calcium and its preparation |
| 09/07/2005 | CN1663570A Pharmaceutical composition with anti-infection, fever-relieving, pain-stopping functions |
| 09/07/2005 | CN1663569A Fructose injection for cardiovascular medicine |
| 09/07/2005 | CN1663568A Compound formulation for effectively preventing and treating virus infection |
| 09/07/2005 | CN1663567A Compound menonine and Vitamin B1 freeze-dried injection and its preparation |
| 09/07/2005 | CN1663566A Itraconazole hydrochloride composition and freeze-dried powder injection thereof |
| 09/07/2005 | CN1663565A Application of camptothecin derivative in drug preparing process for treating marrow originate leukemia |
| 09/07/2005 | CN1663564A Formulation for preventing and treating thrombus disease |
| 09/07/2005 | CN1663563A Compound troxerutin and piracetam formulation and application thereof |
| 09/07/2005 | CN1663562A Application of flavone monomer in antivirus drug preparing process |
| 09/07/2005 | CN1663561A Use of rare earth element salt in preparation of insulin beta cell for treating diabetes |
| 09/07/2005 | CN1663560A Transdermal drug administering system |
| 09/07/2005 | CN1663559A Skin normalizing agents |
| 09/07/2005 | CN1663556A Externally applied drug/cosmetic for inhibiting alopeia or/and promoting hair regeneration |
| 09/07/2005 | CN1663555A Externally applied drug or/and cosmetic for inhibiting alopeia or/and promoting hair regeneration |
| 09/07/2005 | CN1663376A Antimicrobial composition containing N-(N-butyl)-1, 2-benzisothiazolin-3-one |
| 09/07/2005 | CN1217953C Buxanines compounds with cardiovascular activity and cardiovascular and cerebrovascular medicine using them as active component |
| 09/07/2005 | CN1217952C Compound |
| 09/07/2005 | CN1217951C Processes for preparing clarithromycin polymorphs and novel polymorph IV |
| 09/07/2005 | CN1217945C CRF receptor antagonists and methods relating thereto |
| 09/07/2005 | CN1217944C Crystal modification D of 8-cyano-1-cyclopropyl-7-(1S, 6S-2, 8-diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 09/07/2005 | CN1217943C New use and novel N-azabicyclo-amide derivatives |
| 09/07/2005 | CN1217942C Pyrrolidine derivatives having phospholipase A inhibitory activity |
| 09/07/2005 | CN1217939C Compound of phycocyania of blue-green algae, its preparing method and usage |
| 09/07/2005 | CN1217938C Bis-arylsulfones |